
KEY POINTS
- The FDA has removed 'black box' warnings from most hormone therapy drugs after new evidence showed outdated risks.
- Experts say modern HRT can lower the risk of heart disease, fractures, and cognitive decline when started early.
- Doctors urge women to discuss individual health profiles with clinicians before starting hormone therapy.
In a historic decision, the US Food and Drug Administration (FDA) has announced it will remove the 'black box' warnings from most hormone replacement therapy (HRT) medications used to treat menopause. The move, supported by new research and expert consensus, marks a turning point for women's health after more than two decades of fear, stigma, and under-treatment linked to hormone therapy.